185 related articles for article (PubMed ID: 20374252)
1. Non-competitive inhibition by active site binders.
Blat Y
Chem Biol Drug Des; 2010 Jun; 75(6):535-40. PubMed ID: 20374252
[TBL] [Abstract][Full Text] [Related]
2. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
3. An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
Kornacker MG; Lai Z; Witmer M; Ma J; Hendrick J; Lee VG; Riexinger DJ; Mapelli C; Metzler W; Copeland RA
Biochemistry; 2005 Aug; 44(34):11567-73. PubMed ID: 16114893
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A.
Joubert S; McNicoll N; De Léan A
Biochem Pharmacol; 2007 Apr; 73(7):954-63. PubMed ID: 17196175
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
Hrmova M; Fincher GB
Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065
[TBL] [Abstract][Full Text] [Related]
6. Multisubstrate adduct inhibitors: drug design and biological tools.
Le Calvez PB; Scott CJ; Migaud ME
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1291-318. PubMed ID: 19912064
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic differences in inhibition of ubiquinol cytochrome c reductase by the proximal Qo-site inhibitors famoxadone and methoxyacrylate stilbene.
Pember SO; Fleck LC; Moberg WK; Walker MP
Arch Biochem Biophys; 2005 Mar; 435(2):280-90. PubMed ID: 15708371
[TBL] [Abstract][Full Text] [Related]
8. Exosites determine macromolecular substrate recognition by prothrombinase.
Krishnaswamy S; Betz A
Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
[TBL] [Abstract][Full Text] [Related]
9. Electrostatic channeling of substrates between enzyme active sites: comparison of simulation and experiment.
Elcock AH; Huber GA; McCammon JA
Biochemistry; 1997 Dec; 36(51):16049-58. PubMed ID: 9405038
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
Ward NE; O'Brian CA
Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
[TBL] [Abstract][Full Text] [Related]
12. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
13. Enzyme inhibitors as chemical tools to study enzyme catalysis: rational design, synthesis, and applications.
Hiratake J
Chem Rec; 2005; 5(4):209-28. PubMed ID: 16041744
[TBL] [Abstract][Full Text] [Related]
14. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics.
Kolobe D; Sayed Y; Dirr HW
Biochem J; 2004 Sep; 382(Pt 2):703-9. PubMed ID: 15147239
[TBL] [Abstract][Full Text] [Related]
15. A geometry-based generic predictor for catalytic and allosteric sites.
Mitternacht S; Berezovsky IN
Protein Eng Des Sel; 2011 Apr; 24(4):405-9. PubMed ID: 21159618
[TBL] [Abstract][Full Text] [Related]
16. Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.
Peng CC; Rushmore T; Crouch GJ; Jones JP
Bioorg Med Chem; 2008 Apr; 16(7):4064-74. PubMed ID: 18255300
[TBL] [Abstract][Full Text] [Related]
17. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of inhibition of yeast squalene synthase by substrate analog inhibitors.
Kalinowski SS; Mookhtiar KA
Arch Biochem Biophys; 1999 Aug; 368(2):338-46. PubMed ID: 10441385
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors.
Ramarao MK; Shen MW; Murphy EA; Duan W; Zhao Y; McKew J; Lee KL; Thakker P; Behnke ML; Clark JD
Anal Biochem; 2008 Dec; 383(2):217-25. PubMed ID: 18801329
[TBL] [Abstract][Full Text] [Related]
20. Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies.
Sánchez-Sixto C; Prazeres VF; Castedo L; Suh SW; Lamb H; Hawkins AR; Cañada FJ; Jiménez-Barbero J; González-Bello C
ChemMedChem; 2008 May; 3(5):756-70. PubMed ID: 18200648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
